GTranslate

Languages

Amsterdam 90-90-90 Targets (2016) PLHIV: 6,150

94%

93%

95%

Source: Provided by the City of Amsterdam

Amsterdam HIV Care Continuum (2016) PLHIV: 6,150

94%

89%

87%

83%

Source: Provided by the City of Amsterdam

The following counters and charts portray the current epidemiology of HIV. The charts have hovers and are changeable by clicking on them. They are also downloadable-see the download button.

6,150

Source: Provided by the City of Amsterdam

5,774

Source: Provided by the City of Amsterdam

5,472

Source: Provided by the City of Amsterdam

5,354

Source: Provided by the City of Amsterdam

5,100

Source: Provided by the City of Amsterdam

4,500

Source: Provided by the City of Amsterdam

4,259

Source: Provided by the City of Amsterdam

4,104

Source: Provided by the City of Amsterdam

4,018

Source: Provided by the City of Amsterdam

3,840

Source: Provided by the City of Amsterdam

168

Source: Provided by the City of Amsterdam

440

Source: Provided by the City of Amsterdam

439

Source: Provided by the City of Amsterdam

43

Source: Provided by the City of Amsterdam

HIV Monitoring Foundation

Hover on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2016 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV patients living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2016 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2016. People were considered to be on antiretroviral treatment whenever they started combination antiretroviral treatment before the end of 2016. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2016, irrespective of treatment, where people without a measurement in 2016 were considered unsuppressed.

Hover on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2016 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV patients living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2016 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2016. People were considered to be on antiretroviral treatment whenever they started combination antiretroviral treatment before the end of 2016. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2016, irrespective of treatment, where people without a measurement in 2016 were considered unsuppressed.

CD4 count at diagnosis and start cART in Amsterdam

Hover on dots for detailed data.

Number of new diagnoses in the Netherlands and Amsterdam

Hover on dots for detailed data.

HIV Mortality in Amsterdam

Hover on dots for detailed data.